Abstract:Interleukin-33 (IL-33) and its receptor ST2 contribute to spinal glial activation and chronic pain. A recent study showed that peripheral IL-33 plays a pivotal role in the pathogenesis of chronic itch induced by poison ivy. However, how IL-33/ST2 signaling in the spinal cord potentially mediates chronic itch remains elusive. Here, we determined that St2-/- substantially reduced scratching behaviors in 2,4-dinitrofluorobenzene (DNFB)-induced allergic contact dermatitis (ACD) as well as acetone and diethylether followed by water-induced dry skin in mice. Intrathecal administration of the neutralizing anti-ST2 or anti-IL-33 antibody remarkably decreased the scratching response in DNFB-induced ACD mice. Expression of spinal IL-33 and ST2 significantly increased in ACD mice, as evidenced by increased mRNA and protein levels. Immunofluorescence and in situ hybridization demonstrated that increased expression of spinal IL-33 was predominant in oligodendrocytes and astrocytes, whereas ST2 was mainly expressed in astrocytes. Further studies showed that in ACD mice, the activation of astrocytes and increased phosphorylation of signal transducer and activator of transcription 3 (STAT3) were markedly attenuated by St2-/- . Intrathecal injection of Janus Kinase 2 Inhibitor AG490 significantly alleviated scratching behaviors in ACD mice. rIL-33 pretreatment exacerbated gastrin-releasing peptide (GRP)-evoked scratching behaviors. This increased gastrin-releasing peptide receptor (GRPR) expression was abolished by St2-/- . Tnf-α upregulation was suppressed by St2-/- . Our results indicate that the spinal IL-33/ST2 signaling pathway contributes to chronic itch via astrocytic JAK2-STAT3 cascade activation, promoting TNF-α release to regulate the GRP/GRPR signaling-related itch response. Thus, these findings provide a potential therapeutic option for treating chronic pruritus.

Dysregulation of T Lymphocyte Function in Itchy Mice: a Role for Itch in TH2 Differentiation

Regulation of T cell differentiation and allergic responses by the E3 ubiquitin ligase itch.

Itch Expression by Treg Cells Controls Th2 Inflammatory Responses.

TLR3 Deficiency Impairs Spinal Cord Synaptic Transmission, Central Sensitization, and Pruritus in Mice.

The E3 Ligase Itch in Immune Regulation and Beyond

Convergence of Itch-induced Ubiquitination with MEKK1-JNK Signaling in Th2 Tolerance and Airway Inflammation

Toll-Like Receptor 4 Contributes to Chronic Itch, Alloknesis, and Spinal Astrocyte Activation in Male Mice

Recognition and Ubiquitination of Notch by Itch, A Hect-Type E3 Ubiquitin Ligase

The E3 Ubiquitin Ligase Itch is Required for B-cell Development

The E3 Ubiquitin Ligase Itch in T Cell Activation, Differentiation, and Tolerance

The E3 ligases Itch and WWP2 cooperate to limit T H 2 differentiation by enhancing signaling through the TCR

The E3 Ubiquitin Ligase Itch Regulates Expression of Transcription Factor Foxp3 and Airway Inflammation by Enhancing the Function of Transcription Factor TIEG1.

Foxp3 positive regulatory T cells: a functional regulation by the E3 ubiquitin ligase Itch

The E3 ubiquitin ligase Itch is required for the differentiation of follicular helper T cells

VGLUT2-dependent Glutamate Release from Nociceptors is Required to Sense Pain and Suppress Itch.

The Cytokine TGF-β Induces Interleukin-31 Expression from Dermal Dendritic Cells to Activate Sensory Neurons and Stimulate Wound Itching

Cytokines and Chemokines Modulation of Itch

Mechanisms of the PD-1/PD-L1 pathway in itch: From acute itch model establishment to the role in chronic itch in mouse

A basophil-neuronal axis promotes itch

Spinal IL-33/ST2 Signaling Mediates Chronic Itch in Mice Through the Astrocytic JAK2-STAT3 Cascade

Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change.